Skip to main content
Figure 2 | Clinical Epigenetics

Figure 2

From: Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11β-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes

Figure 2

Skeletal muscle 11β-hydroxysteroid dehydrogenase-1 mRNA, C/EBPβ and 11βHSD1 oxoreductase activity before and after dexamethasone. Mean ± standard error of skeletal muscle (a) 11β-hydroxysteroid dehydrogenase-1(11βHSD1) mRNA, (b) CCAAT/enhancer-binding protein (C/EBPβ) and (c) 11βHSD1 oxoreductase activity before (□) and after (■ ) dexamethasone 4 mg/day for 4 days in 15 subjects with type 2 diabetes. *P <0.05, **P <0.01 by Wilcoxon signed-rank test.

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us